Summary & Overview
HCPCS G9188: Beta-Blocker Therapy Not Prescribed, Reason Not Given
HCPCS Level II code G9188 denotes that beta-blocker therapy was not prescribed and no reason was recorded. This code is used in clinical documentation to capture omission of a guideline-recommended medication when the reason for not prescribing is not provided. Accurately capturing such omissions matters nationally because it affects quality measurement, medication reconciliation, and reporting for performance programs tied to cardiovascular care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the code, typical sites where the code is used, and what its presence implies for quality measurement and claims processing. The publication outlines benchmarks and reporting considerations where available and summarizes policy or coding updates relevant to omission reporting. The content is geared to coding managers, compliance officers, and clinical leaders seeking a concise reference on documentation and billing implications for absent beta-blocker therapy when no reason is recorded.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code G9188 indicates beta-blocker therapy not prescribed, reason not given. This code documents that a patient eligible for beta-blocker treatment did not receive a prescription and no reason was recorded.
Service type: Medication management / treatment omission documentation
Typical site of service: Outpatient clinical setting or inpatient hospital setting where medication reconciliation and treatment decisions are documented
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old individual with a history of hypertension and prior myocardial infarction who presents for a medication reconciliation visit in primary care or cardiology. During the visit the clinician documents that beta-blocker therapy is indicated based on ischemic heart disease or heart failure guidelines but the clinician did not prescribe a beta-blocker and did not document a reason for withholding therapy. The workflow typically includes review of current medications, assessment of blood pressure and heart rate, review of allergies and contraindications (for example severe reactive airway disease, bradycardia, or hypotension), and shared decision-making. In this scenario the clinician records that beta-blocker therapy was not prescribed, reason not given, and assigns billing code G9188 to capture this specific reconciliation/documentation outcome. Typical sites of service are outpatient clinic, cardiology office, primary care office, or transitional care visits following hospital discharge. The patient encounter may be part of chronic disease management, medication reconciliation after hospitalization, or quality-measure reporting where documentation of beta-blocker prescription status is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work beyond typical visit is documented (e.g., complex medication reconciliation extending visit time). |